Adient (NYSE:ADNT – Get Free Report) is expected to be posting its Q4 2026 results before the market opens on Wednesday, November 4th. Analysts expect Adient to post earnings of $0.65 per share and revenue of $3.60 billion for the quarter. Parties may visit the company’s upcoming Q4 2026 earnings results page for the latest details on the call scheduled for Wednesday, November 4, 2026 at 8:30 AM ET.
Adient (NYSE:ADNT – Get Free Report) last released its earnings results on Wednesday, August 5th. The company reported $0.48 EPS for the quarter, missing the consensus estimate of $0.56 by ($0.08). Adient had a net margin of 0.32% and a return on equity of 7.32%. The company had revenue of $3.93 billion for the quarter, compared to analyst estimates of $3.71 billion. During the same period in the previous year, the business posted $0.45 EPS. The firm’s quarterly revenue was up 4.3% on a year-over-year basis. On average, analysts expect Adient to post $1.99 EPS for the current fiscal year and $3.11 EPS for the next fiscal year.
Adient Stock Down 0.3%
ADNT stock opened at $16.64 on Monday. The firm’s 50-day moving average is $17.98 and its two-hundred day moving average is $20.58. The company has a market capitalization of $1.28 billion, a price-to-earnings ratio of 27.73, a price-to-earnings-growth ratio of 0.23 and a beta of 1.60. Adient has a 52 week low of $15.91 and a 52 week high of $27.32. The company has a current ratio of 1.10, a quick ratio of 0.91 and a debt-to-equity ratio of 1.18.
Wall Street Analysts Forecast Growth
A number of research analysts recently commented on ADNT shares. JPMorgan Chase & Co. upgraded shares of Adient from a “neutral” rating to an “overweight” rating and lowered their price objective for the company from $28.00 to $25.00 in a research note on Tuesday, September 15th. BNP Paribas Exane upgraded Adient from a “neutral” rating to an “outperform” rating and set a $26.00 target price for the company in a research report on Thursday, July 30th. Morgan Stanley cut their target price on Adient from $22.00 to $21.00 and set an “equal weight” rating for the company in a research report on Tuesday, August 18th. Wall Street Zen lowered Adient from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Finally, Zacks Research upgraded Adient from a “strong sell” rating to a “hold” rating in a research report on Wednesday, September 16th. Seven research analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $24.90.
View Our Latest Report on Adient
Insiders Place Their Bets
In other news, Director Peter Carlin sold 7,843 shares of the firm’s stock in a transaction dated Wednesday, September 2nd. The shares were sold at an average price of $19.25, for a total transaction of $150,977.75. Following the completion of the transaction, the director owned 38,835 shares in the company, valued at approximately $747,573.75. This trade represents a 16.80% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 0.94% of the company’s stock.
About Adient
Adient plc (NYSE: ADNT) is a global automotive supplier specializing in the design, development and manufacture of vehicle seating systems. The company supplies complete seating assemblies as well as components such as seat structures, mechanisms, foam, fabrics, leather and other trim materials.
Adient works with automakers and other automotive customers to provide seating solutions for passenger cars, trucks, sport utility vehicles and commercial vehicles. Its offerings are designed to support vehicle comfort, safety, styling, weight reduction and manufacturing efficiency, with products developed for both traditional and electrified vehicles.
The company was formed in 2016 through the separation of Johnson Controls’ automotive seating business.
Read More
- Five stocks we like better than Adient
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.
